Back to results
US 2004/0082049 A1Published application
Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
AssigneeCell Therapeutics, Inc.
InventorsDavid W. Leung, Daniel Adourel, David Hollenback
Life of this patent
Estimating the term…
Abstract
Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
Claims1
An isolated polypeptide having LPAAT activity, comprising the amino acid sequence SEQ ID NO:
- 15 and enzymatically active fragments thereof.
Dependencies are inferred from the claim text.